Definitely trading at a huge discount to 70-80's. but one has to rememebr that probably had quite abit of blue sky. minus out the reduction in profits recently and I have no idea, but imagine this reduces the price somewhat. Add in the fear of competitors...
The announcement today confirms the hybrid is likely to go through. And one would hope the technology gap with Nucleus 6 will bring in quite abit of money for the company prior to competitors catching up.
By health funds are you referring to health providers, or funds management geared towards investing in the healthcare space?
I dont' think we'll see a huge surge 'yet' into investing/backing a cheap, mass produced chinese product. one would hope (for medical/people's sake as well, in terms of quality) that the better made product is supported. It would be, short of intellectual espionage, hard for them to catchup on the technology gap in such a huge time.
You're right though, the chinese can be real quick to imitate or try and catchup. One wonders if they could just reverse-engineer a nucleus 6 they get their hands on. Illegal and perhaps proprietary knowledge, but we all know what counterfeiting can be like over there.
- Forums
- ASX - By Stock
- COH
- News: Cochlear sales slow
News: Cochlear sales slow , page-71
Featured News
Add COH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$287.29 |
Change
-1.020(0.35%) |
Mkt cap ! $18.80B |
Open | High | Low | Value | Volume |
$287.00 | $288.94 | $285.68 | $26.97M | 93.83K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 378 | $286.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$287.29 | 264 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 378 | 286.770 |
1 | 378 | 286.550 |
1 | 378 | 286.330 |
1 | 1004 | 286.300 |
1 | 79 | 286.230 |
Price($) | Vol. | No. |
---|---|---|
287.290 | 264 | 1 |
287.370 | 527 | 2 |
287.510 | 585 | 1 |
287.680 | 454 | 1 |
287.810 | 378 | 2 |
Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
Featured News
COH (ASX) Chart |